Ondansetron vs Pembrolizumab
Ondansetron vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Ondansetron and Pembrolizumab.
Mechanism of Action
Ondansetron: Selective 5-HT3 receptor antagonist.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Ondansetron — 3-5 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Ondansetron — C18H19N3O.
Molecular Weight: Ondansetron — 293.3660 g/mol.
Type: Ondansetron — Small molecule; Pembrolizumab — Antibody.